Hormonal responses to angiotensin blockade. Comparison between receptor antagonism and converting enzyme inhibition
Johnston, C.I.; Millar, J.A.; Casley, D.J.; McGrath, B.P.; Matthews, P.G.
Circulation Research 46(6 Part 2): I128-I134
1980
ISSN/ISBN: 0009-7330 PMID: 6247084 Document Number: 168290
Document emailed within 1 workday
Related Documents
Spinale, F.G.; Holzgrefe, H.H.; Mukherjee, R.; Webb, M.L.; Hird, R.B.; Cavallo, M.J.; Powell, J.R.; Koster, W.H. 1997: Angiotensin-converting enzyme inhibition and angiotensin Ii subtype-1 receptor blockade during the progression of left ventricular dysfunction: differential effects on myocyte contractile processes Journal of Pharmacology and Experimental Therapeutics 283(3): 1082-1094Sakai, K.; Shiraki, Y.; Akima, M.; Imagawa, J.; Hinohara, Y.; Koga, T.; Ichihara, T.; Tohira, Y. 1988: Tissue angiotensin-converting enzyme blockade by MC-838 (altiopril calcium) infused intravenously to miniature pigs: comparison with captopril Archives Internationales de Pharmacodynamie et de Therapie 294: 228-240
Aurell, M. 1984: Physiological aspects of the renin-angiotensin system and peroral angiotensin converting enzyme inhibition Scandinavian Journal of Urology and Nephrology. Supplementum 79: 9-12
Santucci, A.; Aguglia, F.; De Mattia, G.; Cammarella, I.; Trinchieri, F.; Giordano, M.; Gnecchi, M.; Ficara, C. 1983: Role of the renin-angiotensin-aldosterone system in ascitic hepatic cirrhosis. Effects of inhibition of angiotensin i converting enzyme La Clinica Terapeutica 106(2): 121-124
De Paz, S.; Martín, A.B.; Iglesias, A.; Domínguez, A.R. 1999: Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin Ii receptor antagonists Medicina Clinica 113(19): 759
Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9
Krzesinski, J.M.; Montrieux, C.; Scheen, A.J. 2006: Angiotensin converting enzyme inhibitors or angiotensin Ii receptor blocker in cardiovascular and renal pathology in 2006: what does EBM teach us? Revue Medicale de Liege 61(5-6): 414-422
Squire, I.B.; MacFayden, R.J.; Reid, J.L.; Devlin, A.; Lees, K.R. 1996: Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure Journal of Cardiovascular Pharmacology 27(5): 657-666
Iimura, O.; Kusano, E.; Tanba, K.; Yanagiba, S.; Amemiya, M.; Ando, Y.; Honma, S.; Muto, S.; Asano, Y. 2003: Additive antiproteinuric effect of angiotensin Ii receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis Nihon Jinzo Gakkai Shi 45(5): 439-444
Surabenjawong, U.; Thunpiphat, N.; Chatsiricharoenkul, S.; Monsomboon, A. 2013: Prevalence of hyperkalemia in adult patients taking spironolactone and angiotensin converting enzyme inhibitors or angiotensin receptor blockers Journal of the Medical Association of Thailand 96(8): 905-910
Anantharaman, R.; Bhansali, A.; Bhadada, S.K.; Kohli, H.S.; Dutta, P.; Walia, R.; Jayaprakash, P.; Upreti, V. 2010: Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor and angiotensin receptor blocker in type 1 DM with nephropathy Indian Journal of Medical Research 132: 42-47
Humke, U.; Levens, N.; Wood, J.; Hofbauer, K. 1992: The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system Journal of Pharmacology and Experimental Therapeutics 260(1): 29-35
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin converting enzyme inhibitors and angiotensin Ii receptor blockers on angiogenesis of gastric cancer in a nude mouse model Zhonghua Wei Chang Wai Ke Za Zhi 11(6): 565-568
Benetos, A.; Gautier, S.; Ricard, S.; Topouchian, J.; Asmar, R.; Poirier, O.; Larosa, E.; Guize, L.; Safar, M.; Soubrier, F.; Cambien, F. 1996: Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients Circulation 94(4): 698-703
Biollaz, J.; Brunner, H.R.; Gavras, I.; Waeber, B.; Gavras, H. 1982: Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade Journal of Cardiovascular Pharmacology 4(6): 966-972
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin-converting enzyme inhibitors and angiotensin Ii type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model Chinese Medical Journal 121(21): 2167-2171
Zhou, H.; Bian, Y-fei.; Li, M-lian.; Gao, F.; Xiao, C-shi. 2010: Effects of RNA interference targeting angiotensin 1 receptor and angiotensin-converting enzyme on blood pressure and myocardial remodeling in spontaneous hypertensive rats Zhonghua Xin Xue Guan Bing Za Zhi 38(1): 60-66
Campbell, D.J.; Anastasopoulos, F.; Duncan, A.M.; James, G.M.; Kladis, A.; Briscoe, T.A. 1998: Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats Journal of Pharmacology and Experimental Therapeutics 287(2): 567-577
Diskin, C.J.; Stokes, T.J.; Dansby, L.M.; Radcliff, L.; Carter, T.B. 2007: Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker? Journal of Nephrology 20(4): 410-416
Zhang, R.-y.; Huang, Y.-l.; Sun, Y.-h. 2005: Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase Zhonghua Yi Xue Za Zhi 85(15): 1053-1056